Allogene Therapeutics (NasdaqGS:ALLO) Conference Transcript

Allogene Therapeutics (NasdaqGS:ALLO) Conference November 12, 2025 04:30 PM ET Speaker1Great. Good afternoon, everyone, and welcome again to TD Cowen's I&I Summit. My name is Tyler Van Buren, Senior Biotechnologist here at TD Cowen. Thank you for joining. Very pleased to be hosting a session with Allogene. From Allogene, it's my pleasure to introduce David Chang, Co-founder, President, and CEO of Allogene. David, thank you very much for joining me.Speaker0Tyler, thanks for the nice introduction, and great t ...